MUC1 and adenocarcinoma: The pattern of reactivity exhibited by serum samples from patients with adenocarcinoma can be explained by the reduced glycan chain lengths on tumor-associated MUC1, which facilitate the accessibility to the invariant peptide core, and enable immune responses to it [95].